Cytarabine, cisplatin, and etoposide chemotherapy for refractory non-Hodgkin's lymphoma.
Cancer Treat Rep
; 71(2): 187-9, 1987 Feb.
Article
em En
| MEDLINE
| ID: mdl-3802114
ABSTRACT
A phase II trial of cytarabine, cisplatin, and etoposide was conducted in 38 patients with refractory stage III and IV non-Hodgkin's lymphoma. There were two complete and nine partial responses (32%) among 35 evaluable patients. Response rate in patients with large cell lymphoma was 45%. The dose-limiting toxic effect was myelosuppression in 66% of patients.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Linfoma não Hodgkin
/
Protocolos de Quimioterapia Combinada Antineoplásica
Limite:
Female
/
Humans
/
Male
Idioma:
En
Ano de publicação:
1987
Tipo de documento:
Article